Ellen Blanc

756 total citations
34 papers, 524 citations indexed

About

Ellen Blanc is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ellen Blanc has authored 34 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Ellen Blanc's work include Renal cell carcinoma treatment (17 papers), Cancer Genomics and Diagnostics (9 papers) and Renal and related cancers (8 papers). Ellen Blanc is often cited by papers focused on Renal cell carcinoma treatment (17 papers), Cancer Genomics and Diagnostics (9 papers) and Renal and related cancers (8 papers). Ellen Blanc collaborates with scholars based in France, United States and Belgium. Ellen Blanc's co-authors include Bernard Escudier, Céline Ferlay, Sylvie Négrier, David Pérol, Christine Chevreau, Gwénaëlle Gravis, R. Delva, Frédéric Rolland, Éric Legouffe and Lionnel Geoffrois and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and British Journal of Cancer.

In The Last Decade

Ellen Blanc

32 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ellen Blanc France	12	357	278	180	139	58	34	524
Sven Gogov Switzerland	12	409 1.1×	294 1.1×	145 0.8×	351 2.5×	36 0.6×	25	804
Delphine Topart France	12	234 0.7×	122 0.4×	231 1.3×	425 3.1×	52 0.9×	29	606
Francesca Mazzoni Italy	18	470 1.3×	178 0.6×	160 0.9×	568 4.1×	67 1.2×	63	821
Xiaojuan Zhang China	11	260 0.7×	144 0.5×	83 0.5×	259 1.9×	29 0.5×	39	515
Jianzhong Cao China	15	277 0.8×	232 0.8×	150 0.8×	253 1.8×	75 1.3×	58	620
Qi Xia United States	9	216 0.6×	206 0.7×	134 0.7×	122 0.9×	82 1.4×	26	418
Guido Carillio Italy	16	265 0.7×	221 0.8×	159 0.9×	396 2.8×	154 2.7×	47	772
Emanuela Dell’Aquila Italy	12	189 0.5×	171 0.6×	242 1.3×	362 2.6×	56 1.0×	41	593
Toshiaki Shinojima Japan	15	290 0.8×	273 1.0×	180 1.0×	196 1.4×	85 1.5×	46	664
Ivana Sullivan Spain	14	322 0.9×	218 0.8×	100 0.6×	509 3.7×	47 0.8×	55	686

Countries citing papers authored by Ellen Blanc

Since Specialization

Citations

This map shows the geographic impact of Ellen Blanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Blanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Blanc more than expected).

Fields of papers citing papers by Ellen Blanc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Blanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Blanc. The network helps show where Ellen Blanc may publish in the future.

Co-authorship network of co-authors of Ellen Blanc

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Blanc. A scholar is included among the top collaborators of Ellen Blanc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Blanc. Ellen Blanc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Négrier, Sylvie, Loı̈c Mourey, Ellen Blanc, et al.. (2025). Cabozantinib in patients (pts) with non-locally pretreated brain metastases (BM) from renal cell carcinoma (RCC): Results of the multicenter CABRAMET phase II trial (NCT03967522).. Journal of Clinical Oncology. 43(5_suppl). 533–533. 1 indexed citations

Bibeau, Frédéric, et al.. (2025). Assessment of pathologic response in the colorectal cancer cohort of the IMHOTEP phase II trial of neoadjuvant pembrolizumab in dMMR/MSI tumors.. Journal of Clinical Oncology. 43(4_suppl). 241–241. 1 indexed citations

Guitton, Jérôme, Perrine Marec‐Bérard, Cécile Faure‐Conter, et al.. (2024). Renal toxicity of ifosfamide in children with cancer: an exploratory study integrating aldehyde dehydrogenase enzymatic activity data and a wide-array urinary metabolomics approach. BMC Pediatrics. 24(1). 196–196.

Fouchardière, Christelle de la, Robert Cohen, Olivier Dubreuil, et al.. (2024). 1448P IMHOTEP phase II trial of neoadjuvant pembrolizumab in dMMR/MSI localized cancers: Results of the digestive non-colorectal cancer cohorts. Annals of Oncology. 35. S899–S900. 4 indexed citations

Rioux‐Leclercq, Nathalie, Maxime Meylan, Christophe Passot, et al.. (2023). Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 11(11). e006885–e006885. 8 indexed citations

Fouchardière, Christelle de la, Pia Gamradt, Sylvie Chabaud, et al.. (2022). A Promising Biomarker and Therapeutic Target in Patients with Advanced PDAC: The Stromal Protein βig-h3. Journal of Personalized Medicine. 12(4). 623–623. 2 indexed citations

Faure‐Conter, Cécile, Daniel Orbach, Hélène Sudour‐Bonnange, et al.. (2022). Extracranial germ cell tumours in children and adolescents: Results from the French TGM13 protocol. Pediatric Blood & Cancer. 70(3). e30117–e30117. 3 indexed citations

Sunyach, Marie‐Pierre, Nicolas Penel, Philippe A. Cassier, et al.. (2022). Sunitinib with concomitant radiation therapy in inoperable sarcomas: Final results from the dose escalation and expansion parts of a multicenter phase I study. Radiotherapy and Oncology. 168. 95–103. 4 indexed citations

Blanc, Ellen, Anne Ducassou, A. Huchet, et al.. (2021). Hypofractionated stereotactic body radiation therapy (SBRT) in pediatric patients: preliminary toxicity results of a national prospective multicenter study. British Journal of Radiology. 94(1125). 20210176–20210176. 8 indexed citations

10.

Khan, Waheed N., et al.. (2020). Reasons for intravesical instillation postponement during adjuvant treatment of non-muscle-invasive bladder cancer: A prospective study. Progrès en Urologie. 30(2). 75–79.

11.

Négrier, Sylvie, Céline Ferlay, Marine Gross‐Goupil, et al.. (2020). Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial. European Journal of Cancer. 129. 107–116. 45 indexed citations

12.

Chvetzoff, Gisèle, et al.. (2019). Étude randomisée monocentrique évaluant l’efficacité de l’ostéopathie dans la prise en charge des douleurs chroniques après chirurgie mammaire en oncologie. Bulletin du Cancer. 106(5). 436–446. 6 indexed citations

13.

Peyrat, Patrice, Ellen Blanc, Céline Ferlay, et al.. (2018). HEPATOFLUO: A prospective monocentric study assessing the benefits of indocyanine green (ICG) fluorescence for hepatic surgery. Journal of Surgical Oncology. 117(5). 922–927. 20 indexed citations

14.

Dufies, Maeva, Adama Sidibé, A. Salomón, et al.. (2018). The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma. British Journal of Cancer. 118(9). 1179–1188. 24 indexed citations

15.

Blanc, Ellen, et al.. (2018). A 96‐hour continuous wound infiltration with ropivacaine reduces analgesic consumption after liver resection: A randomized, double‐blind, controlled trial. Journal of Surgical Oncology. 119(1). 47–55. 8 indexed citations

16.

Dupré, Aurélien, David Pérol, Ellen Blanc, et al.. (2017). Efficacy of high-intensity focused ultrasound-assisted hepatic resection (HIFU-AR) on blood loss reduction in patients with liver metastases requiring hepatectomy: study protocol for a randomized controlled trial. Trials. 18(1). 57–57. 11 indexed citations

17.

Négrier, Sylvie, David Pérol, Rastislav Bahleda, et al.. (2017). Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors. BMC Cancer. 17(1). 547–547. 4 indexed citations

18.

Jobard, Élodie, Ellen Blanc, Sylvie Négrier, et al.. (2015). A serum metabolomic fingerprint of bevacizumab and temsirolimus combination as first-line treatment of metastatic renal cell carcinoma. British Journal of Cancer. 113(8). 1148–1157. 22 indexed citations

19.

Gigante, Marc, Guorong Li, Céline Ferlay, et al.. (2012). Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapy.. PubMed. 32(12). 5447–51. 21 indexed citations

20.

Négrier, Sylvie, Gwénaëlle Gravis, David Pérol, et al.. (2011). Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial. The Lancet Oncology. 12(7). 673–680. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact